Treatment with combined dabrafenib and trametinib in BRAFV600E-mutated metastatic malignant melanoma: a case of long-term complete response after treatment cessation

Here, we report the case of a patient, diagnosed with BRAFV600E-mutated metastatic malignant melanoma M1a, who achieved a complete metabolic response after 7 months of treatment with the combination of dabrafenib and trametinib. After 31 months, the treatment was interrupted for patient's decis...

Full description

Saved in:
Bibliographic Details
Main Authors: Sonia Brugnara (Author), Mariacristina Sicher (Author), Elena Maria Bonandini (Author), Davide Donner (Author), Franca Chierichetti (Author), Mattia Barbareschi (Author), Carlo Renè Girardelli (Author), Orazio Caffo (Author)
Format: Book
Published: BioExcel Publishing Ltd, 2018-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available